Overall rank by patents
#28,376
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Claremont Biosolutions Llc
USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, active 2016–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME).
9
Total patents granted
7
CPC technology areas
15.8
Avg claims per patent
+25%
5-year filing velocity
The verdict
Claremont holds 9 US patents across 7 technology areas, rank #28,376 of 50,000 tracked assignees.
- #28,376
- of 50,000 US assignees by volume
- Top 20%
- by Innovation Score (46.8/100)
- 15.8
- avg claims per patent
- +25%
- filing velocity, last 5 yrs
Portfolio overview
Claremont Biosolutions Llc has been granted 9 US utility patents between 2016 and 2023, placing Claremont Biosolutions Llc at rank #28,376 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.8 claims per patent with primary concentration in C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME). As a US Corporation, Claremont Biosolutions Llc is one of the more focused assignees in the PatentsView dataset. By volume, Claremont sits between CIMA LABS Inc. (9 patents, rank #28,372) and Clever Co., Ltd. (9 patents, rank #28,380) - the closest US assignees by grant volume. The composite Innovation Score of 46.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 4 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Claremont Biosolutions Llc's 15.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Claremont Biosolutions Llc against peers pursuing similar technology classes.
Who files at Claremont's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- CIMA LABS
CIMA LABS INC.
9 patents
- Cirius Messaging
CIRIUS MESSAGING INC.
9 patents
- Cisdi Engineering
CISDI ENGINEERING CO., LTD.
9 patents
- CJ 4dplex
CJ 4DPLEX CO., LTD.
9 patents
- Classic Connectors
CLASSIC CONNECTORS, INC.
9 patents
- Clean IO
CLEAN.IO, INC.
9 patents
- Clement Clarke In…
CLEMENT CLARKE INTERNATIONAL LTD.
9 patents
- Clever
CLEVER CO., LTD.
9 patents
- Claremont Biosolu… ◀
CLAREMONT BIOSOLUTIONS LLC
9 patents
What this shows Claremont holds 9 patents at rank #28,376, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Claremont
By rank, the assignees closest to #28,376 in granted patent volume.
- CIMA LABS Inc. #28,372 · 9 patents
- Cirius Messaging Inc. #28,373 · 9 patents
- Cisdi Engineering Co., Ltd. #28,374 · 9 patents
- CJ 4dplex Co., Ltd. #28,375 · 9 patents
- Classic Connectors, Inc. #28,377 · 9 patents
- Clean.io, Inc. #28,378 · 9 patents
- Clement Clarke International Ltd. #28,379 · 9 patents
- Clever Co., Ltd. #28,380 · 9 patents
Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)
Other assignees with the most granted patents in Claremont's primary technology class.
- Life Technologies Corporation 110 in class
- Sartorius Stedim Biotech Gmbh 84 in class
- Global Life Sciences Solutions USA Llc 75 in class
- President And Fellows Of Harvard College 73 in class
- Inscripta Inc. 70 in class
- Flodesign Sonics, Inc. 64 in class
- Emulate, Inc. 61 in class
- EMD Millipore Corporation 57 in class
Claremont's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 22.2% |
| 2018 | 2 | 22.2% |
| 2020 | 1 | 11.1% |
| 2022 | 3 | 33.3% |
| 2023 | 1 | 11.1% |
Which technologies does Claremont Biosolutions Llc patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing
Frequently Asked Questions
How many patents does Claremont Biosolutions Llc hold?
Claremont Biosolutions Llc holds 9 US granted patents filed between 2016 and 2023, spanning 7 technology areas.
What is Claremont Biosolutions Llc's Innovation Score?
Claremont Biosolutions Llc has an Innovation Score of 46.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Claremont Biosolutions Llc focus on?
Claremont Biosolutions Llc's top technology area is C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS) with 6 patents. The company has filed patents in 7 CPC subclasses total.
Is Claremont Biosolutions Llc's patent filing rate increasing or decreasing?
Claremont Biosolutions Llc's recent filing velocity is +25% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Claremont Biosolutions Llc's patents?
Claremont Biosolutions Llc's patents average 15.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Claremont Biosolutions Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Claremont's 9 grants land it in the top 20% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Claremont ranks #28,376 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C12M - see who else leads that technology area. C12M leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.